EGFR and non-small cell lung carcinoma: first reported that a patient with advanced NSCLC, who was initially diagnosed with poorly differentiated carcinoma and without EGFR gene mutation, experienced histological transformation into SCLC after immunotherapy resistance to nivolumab (6).